Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7106589

CCOC(=O)c1cn(Cc2cccc(/C=N\N)c2)cc1Cc1ccc(C(N)=O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.34
PDE3B Q13370 5/20 0.33
PDE3A Q14432 5/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.32
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32
MAPT P10636 1/20 0.32
F10 P00742 1/20 0.32
NPC1 O15118 2/20 0.32
ALDH1A1 P00352 2/20 0.32
POLB P06746 1/20 0.32
KDM4E B2RXH2 2/20 0.32
PDE4B Q07343 1/20 0.32
PDE4D Q08499 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7106592 1.00 GRM2 (0.34) GRM2PDE3BPDE3ASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL6161844 0.94 PDE3B (0.38) PDE3BPDE3ASMN1; SMN2KMT2ATSHR
Trifluoroacetic Acid SCHEMBL6161851 0.94 PDE3B (0.38) PDE3BPDE3ASMN1; SMN2KMT2ATSHR
Trifluoroacetic Acid SCHEMBL6167880 0.93 SMN1; SMN2 (0.34) PDE3BPDE3ASMN1; SMN2KMT2AMAPT
Trifluoroacetic Acid SCHEMBL6167885 0.93 SMN1; SMN2 (0.34) PDE3BPDE3ASMN1; SMN2KMT2AMAPT
Trifluoroacetic Acid SCHEMBL6165985 0.92 KLKB1 (0.33) PDE3BPDE3ASMN1; SMN2KMT2AMAPT
Trifluoroacetic Acid SCHEMBL6165992 0.92 KLKB1 (0.33) PDE3BPDE3ASMN1; SMN2KMT2AMAPT
Trifluoroacetic Acid SCHEMBL6164140 0.92 PDE3B (0.32) GRM2PDE3BPDE3ASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL6164145 0.92 PDE3B (0.32) GRM2PDE3BPDE3ASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL6165679 0.90 EPHX2 (0.40) MAPTF10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US claimed
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI GRM2 4707/4885PDE3B 211/4885PDE3A 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.